Characteristics of Participants
ADVERSE EVENTS
A total of 157 participants were assessed for eligibility. Of these, 74 participants (47.1%) agreed to participate and provided written consent (mean [SD] age, 46.34 [14.52] years; 38 men [51.4%] and 36 women [48.6%]); 37 participants each were randomized to the intervention and control groups. All participants in both the intervention and control groups completed the interventions and follow-up assessments at the end of the clinic session, except for 1 participant in the control group who was discharged before data collection. No major adverse events were reported. Therefore, the overall attrition rate at T1 and T2 was 0%, and the attrition rate was 0% in the intervention group and 2.7% in the control group. The 